NCT02712996View on ClinicalTrials.gov

Treatment of Traumatic Brain Injury (TBI)-Related Attention Deficits in Children

PHASE4CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

February 6, 2017

Primary Completion Date

July 1, 2019

Study Completion Date

July 1, 2019

Conditions
Traumatic Brain InjuryAttention Deficit Disorder
Interventions
DRUG

Lisdexamfetamine

Lisdexamfetamine (Vyvanse) capsule, 20-70 mg, each morning for 6 weeks.

DRUG

Placebo

Placebo capsule, 20-70 mg, each morning for 6 weeks.

Trial Locations (1)

37203

Vanderbilt Medical Center, Nashville

Sponsors

Collaborators (1)

Shire
All Listed Sponsors
collaborator

Shire

INDUSTRY

lead

Vanderbilt University

OTHER